Navigation Links
ReimbursementIQ Offers “Impact Analytics” Training Sessions to Life Science Leaders
Date:9/29/2018

ReimbursementIQ is offering two-hour executive briefings on “Impact Analytics” to chief officers of Life Science companies. The in-person briefings are expected to transform Medical Affairs, Market Access, and Marketing functions by revealing the extreme visibility that data science is bringing to the U.S. healthcare market—especially to individuals, employers, and other healthcare purchasers.

“Health plan buyers want more value for their money,” explained Jan Alvarado, General Manager of ReimbursementIQ. “Life Science leaders need to understand the level of transparency that data science gives those bearing the burden of healthcare cost escalation.”

In an April 5, 2018 report, the Pharmaceutical Research and Manufacturers Association (PhRMA) highlighted 39 value-based contracts between pharmaceutical companies and savings-minded healthcare stakeholders. The bulk of these purchasing arrangements centered on discounted, bundled, capitated, pay-for-performance, and outcomes-driven pricing with payers.

“Next-generation contracts will move toward 360-degree impact accountability across stakeholders,” said Synthia Laura Molina, ReimbursementIQ’s Vice President of Strategic Business Development. “We see data science vendors offering healthcare purchasers greater visibility into the human, business, and social results of clinical interventions. The Life Science sector can no longer expect business as usual.”

ReimbursementIQ’s two-hour briefings describe the competencies that mission-driven Life Science companies need to win next-generation value-based contracts, meet new performance, outcomes and impact accountabilities and deliver lasting results.

The briefings feature three health industry pioneers and how each has improved performance, outcomes, and impacts at the level of community care, healthcare, and self-care. Life Science leaders get first-hand exposure to state-of-the-art data visualizations, dashboards, and scorecards that provide real-time reporting.

With 360-degree accountability on the horizon, Life Science executives learn how their Medical Affairs, Market Access, and Marketing teams should use impact analytics to

  • improve economic, clinical, and humanistic outcomes (ECHOs);
  • achieve the Triple/Quadruple Aim of reduced per capita costs, improved population health, and enhanced experiences of patients and providers;
  • reduce the incidence, prevalence, and cost of diseases and other adverse conditions;
  • increase the wellbeing, productive capacity, and socioeconomic status of individuals, organizations, and communities; and
  • contribute to a better functioning society.

Briefed on U.S. healthcare’s digital transformation and growing transparencies, Life Science leaders attending “Impact Analytics” briefings will gain strategic advantages in value-based, impact-accountable contracting.

To inquire about a briefing, visit reimbursementiq.com or write smolina(at)reimbursementiq(dot)com.

About ReimbursementIQ

ReimbursementIQ offers data science, strategic consulting, and hands-on support services that help healthcare stakeholders reduce the incidence, prevalence, and cost of diseases and other adverse conditions. The firm advocates, accelerates, and facilitates access to the industry’s most safe, effective, and cost-saving healthcare products, services, and solutions—especially in direct-to-consumer (DTC) and managed markets. Founded in 1988, ReimbursementIQ has served more than two-thirds of the top 25 biopharmaceutical and medical device companies worldwide; forward-looking healthcare providers; and pioneering healthcare purchasers. A member of the xIQ Family of Companies, ReimbursementIQ offers unique expertise at the convergence of the data sciences, life sciences, and social sciences—all focused on improving the performance, outcomes, and impacts of people, products, and programs in the health, education, and social service sectors.

For more information, please contact:

Synthia Laura Molina
ReimbursementIQ
Email:    smolina(at)reimbursementiq(dot)com
Phone:    877-777-0149
Fax:    877-777-0164

Read the full story at https://www.prweb.com/releases/reimbursementiq_offers_impact_analytics_training_sessions_to_life_science_leaders/prweb15802584.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. AegisCare Offers Specialized Home Health Care for Dementia and Alzheimers Patients
2. Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system
3. New report offers science-based strategies for management of western free-ranging horses and burros
4. Gene offers an athletes heart without the exercise
5. Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies
6. First-ever therapeutic offers hope for improving blood transfusions
7. MacaInfo.org Offers In-Depth Answers the 20 Most Common Questions People Have about Maca
8. Prohormonesdirect.com Offers in Depth OxyELITE Pro Reviews
9. New treatment offers hope for short-bowel syndrome patients
10. Major global analysis offers hope for saving the wild side of staple food crops
11. Honey bee gene targeting offers system to understand food-related behavior
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2018)... ... October 11, 2018 , ... ... vision behind the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The Institute, ... designed to advance biopharmaceutical manufacturing and workforce development in the United States. Biopharmaceuticals ...
(Date:10/5/2018)... (PRWEB) , ... October 04, 2018 , ... High dose ... some of the tests such as cardiac troponin has serious clinical complications. There is ... the exact prevalence is still unknown. , High dose of biotin supplement use ...
(Date:10/2/2018)... ... 02, 2018 , ... Stuart is a fun-loving eight-year-old Labrador retriever. Like many labs, Stuart’s ... “He loves playing ball so much that whenever anyone comes to our door, he grabs ... of fetch.” In early 2017, Stuart began limping and eventually could no longer play ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... , ... October 02, 2018 , ... ... ignored, contamination endangers the reliability and reproducibility of experimental data. Each lab must ... In this educational webinar, which is sponsored by Eppendorf , attendees will ...
(Date:9/28/2018)... NEW YORK (PRWEB) , ... September 28, 2018 ... ... Medical Laboratory Services (PMLS) to increase the availability of the GlycoMark test, the ... patients with diabetes. With the partnership, PMLS will promote and offer the GlycoMark ...
(Date:9/27/2018)... ... 2018 , ... Consumers adopting new health care technologies like ... to a new Zeldis Research and Schlesinger Group study, “The Consumerization of Health ... of fitness and health wearables, remote monitoring, patient portals and other convenience products ...
(Date:9/27/2018)... ... September 27, 2018 , ... This past weekend ... SureAdhere Mobile Technology, Inc. announced they will formally merge companies and integrate their ... tuberculosis (TB) and other diseases. These two social enterprise corporations, both of which ...
Breaking Biology Technology: